Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a phase 1 study.
Gevaert P, De Craemer J, De Ruyck N, Rottey S, de Hoon J, Hellings PW, Volckaert B, Lesneuck K, Orengo JM, Atanasio A, Kamal MA, Abdallah H, Kamat V, Dingman R, DeVeaux M, Ramesh D, Perlee L, Wang CQ, Weinreich DM, Herman G, Yancopoulos GD, O'Brien MP. Gevaert P, et al. Among authors: de ruyck n. J Allergy Clin Immunol. 2022 Jan;149(1):189-199. doi: 10.1016/j.jaci.2021.05.039. Epub 2021 Jun 11. J Allergy Clin Immunol. 2022. PMID: 34126156 Free article. Clinical Trial.
T-cell regulation in chronic paranasal sinus disease.
Van Bruaene N, Pérez-Novo CA, Basinski TM, Van Zele T, Holtappels G, De Ruyck N, Schmidt-Weber C, Akdis C, Van Cauwenberge P, Bachert C, Gevaert P. Van Bruaene N, et al. Among authors: de ruyck n. J Allergy Clin Immunol. 2008 Jun;121(6):1435-41, 1441.e1-3. doi: 10.1016/j.jaci.2008.02.018. J Allergy Clin Immunol. 2008. PMID: 18423831
TGF-beta signaling and collagen deposition in chronic rhinosinusitis.
Van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, De Ruyck N, Cuvelier C, Van Cauwenberge P, Bachert C. Van Bruaene N, et al. Among authors: de ruyck n. J Allergy Clin Immunol. 2009 Aug;124(2):253-9, 259.e1-2. doi: 10.1016/j.jaci.2009.04.013. Epub 2009 Jun 4. J Allergy Clin Immunol. 2009. PMID: 19500825
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis.
Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, De Ruyck N, Blomme K, Sousa AR, Marshall RP, Bachert C. Gevaert P, et al. Among authors: de ruyck n. J Allergy Clin Immunol. 2011 Nov;128(5):989-95.e1-8. doi: 10.1016/j.jaci.2011.07.056. Epub 2011 Sep 28. J Allergy Clin Immunol. 2011. PMID: 21958585 Free article. Clinical Trial.
Inflammation and remodelling patterns in early stage chronic rhinosinusitis.
Van Bruaene N, C PN, Van Crombruggen K, De Ruyck N, Holtappels G, Van Cauwenberge P, Gevaert P, Bachert C. Van Bruaene N, et al. Among authors: de ruyck n. Clin Exp Allergy. 2012 Jun;42(6):883-90. doi: 10.1111/j.1365-2222.2011.03898.x. Clin Exp Allergy. 2012. PMID: 22093003
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma.
Gevaert P, Calus L, Van Zele T, Blomme K, De Ruyck N, Bauters W, Hellings P, Brusselle G, De Bacquer D, van Cauwenberge P, Bachert C. Gevaert P, et al. Among authors: de bacquer d, de ruyck n. J Allergy Clin Immunol. 2013 Jan;131(1):110-6.e1. doi: 10.1016/j.jaci.2012.07.047. Epub 2012 Sep 27. J Allergy Clin Immunol. 2013. PMID: 23021878 Clinical Trial.
Inflammatory patterns in upper airway disease in the same geographical area may change over time.
Katotomichelakis M, Tantilipikorn P, Holtappels G, De Ruyck N, Feng L, Van Zele T, Muangsomboon S, Jareonchasri P, Bunnag C, Danielides V, Cuvelier CA, Hellings PW, Bachert C, Zhang N. Katotomichelakis M, et al. Among authors: de ruyck n. Am J Rhinol Allergy. 2013 Sep-Oct;27(5):354-60. doi: 10.2500/ajra.2013.27.3922. Epub 2013 May 14. Am J Rhinol Allergy. 2013. PMID: 23816657
37 results